Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 USD | +0.24% | -2.74% | +1.07% |
12:33pm | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
05-13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.07% | 461M | |
+29.48% | 48.16B | |
-0.59% | 41.73B | |
+43.06% | 41.03B | |
-5.31% | 28.77B | |
+10.13% | 25.59B | |
-22.57% | 18.96B | |
+8.93% | 12.92B | |
+28.69% | 12.03B | |
-2.30% | 11.77B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics : Raymond James Downgrades Voyager Therapeutics to Market Perform From Outperform